Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Aug;115(6):495-501.
doi: 10.1111/vox.12937. Epub 2020 May 14.

Inactivation of severe acute respiratory syndrome coronavirus 2 in plasma and platelet products using a riboflavin and ultraviolet light-based photochemical treatment

Shawn D Keil  1 , Izabela Ragan  2 , Susan Yonemura  1 , Lindsay Hartson  3 , Nicole K Dart  1 , Richard Bowen  2
Affiliations

Inactivation of severe acute respiratory syndrome coronavirus 2 in plasma and platelet products using a riboflavin and ultraviolet light-based photochemical treatment

Shawn D Keil et al. Vox Sang. 2020 Aug.

Abstract

Background and objective: Severe acute respiratory distress syndrome coronavirus-2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), is a member of the coronavirus family. Coronavirus infections in humans are typically associated with respiratory illnesses; however, viral RNA has been isolated in serum from infected patients. Coronaviruses have been identified as a potential low-risk threat to blood safety. The Mirasol Pathogen Reduction Technology (PRT) System utilizes riboflavin and ultraviolet (UV) light to render blood-borne pathogens noninfectious, while maintaining blood product quality. Here, we report on the efficacy of riboflavin and UV light against the pandemic virus SARS-CoV-2 when tested in both plasma and platelets units.

Materials and methods: Stock SARS-CoV-2 was grown in Vero cells and inoculated into either plasma or platelet units. Those units were then treated with riboflavin and UV light. The infectious titres of SARS-CoV-2 were determined by plaque assay using Vero cells. A total of five (n = 5) plasma and three (n = 3) platelet products were evaluated in this study.

Results: In both experiments, the measured titre of SARS-CoV-2 was below the limit of detection following treatment with riboflavin and UV light. The mean log reductions in the viral titres were ≥3·40 and ≥4·53 for the plasma units and platelet units, respectively.

Conclusion: Riboflavin and UV light effectively reduced the titre of SARS-CoV-2 in both plasma and platelet products to below the limit of detection in tissue culture. The data suggest that the process would be effective in reducing the theoretical risk of transfusion transmitted SARS-CoV-2.

Keywords: COVID-19; SARS-CoV-2; blood; pathogen reduction; riboflavin; ultraviolet.

PubMed Disclaimer

Conflict of interest statement

S.K., S.Y. and N.D. are employees of Terumo BCT, the manufacturer of the technology described in this article. I.R., L.H. and R.B. have no conflicts of interest to declare.

References

    1. Zhu N, Zhang D, Wang W, et al.: A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020; 382:727–733 - PMC - PubMed
    1. Lu H, Stratton CW, Tang YW: Outbreak of pneumonia of unknown etiology in Wuhan, China: the mystery and the miracle. J Med Virol 2020; 92:401–402 - PMC - PubMed
    1. Coronaviridae Study Group of the International Committee on Taxonomy of V : The species Severe acute respiratory syndrome‐related coronavirus: classifying 2019‐nCoV and naming it SARS‐CoV‐2. Nat Microbiol 2020; 5:536–544 - PMC - PubMed
    1. de Wit E, van Doremalen N, Falzarano D, et al.: SARS and MERS: recent insights into emerging coronaviruses. Nat Rev Microbiol 2016; 14:523–534 - PMC - PubMed
    1. Wevers BA, van der Hoek L: Recently discovered human coronaviruses. Clin Lab Med 2009; 29:715–724 - PMC - PubMed